HIV News and Research

RSS

Federally funded Obria prescribes abstinence to stop the spread of STDs

Inside Obria Medical Clinics, conviction — not condoms — is summoned to stop the spread of chlamydia.

7 Oct 2019

HIV-1 Tat expression leads to perturbations in cellular protein expression, research suggests

The cover for issue 54 of Oncotarget features Figure 2, "Comparative proteomic profiling of the peptides/proteins identified from 293T, IL16lamp2b and mExo-Tat samples," by Lu, et al.

4 Oct 2019

Study sheds new light on transmission dynamics of HIV-1B virus in Indonesia

Research into the molecular phylogeny (evolutionary history) of the HIV-1B virus in Indonesia has succeeded in illuminating the transmission period and routes for three clades (main branches of the virus).

4 Oct 2019

New $4.5 million federal grant to make more HIV testing available in the Chicago area

More HIV testing will be available in the Chicago area, thanks to a five-year, $4.5 million federal public health grant recently awarded to the University of Chicago Medicine.

3 Oct 2019

Transgender people have difficult time in finding a health care setting

Transgender people who are also racial and ethnic minorities have a difficult time finding a health care setting where all aspects of their identity are welcome, understood and addressed.

3 Oct 2019

High-resolution imaging shows how HIV spreads between living cells

In order to treat diseases better, we must understand how they arise.

3 Oct 2019

Leading experts to discuss about emergence and growing use of point-of-care testing

Point-of-care testing is transforming healthcare: this type of testing helps patients get diagnosed and treated faster, and also makes it easier for patients in remote areas to have access to medical testing.

2 Oct 2019

New study shows response to HIV vaccine in 6 weeks

A US study on DNA-based and protein HIV vaccines has shown that an antibody and cellular immune response occurs within six weeks.

2 Oct 2019

New study shows response to HIV vaccine in 6 weeks

A new study using DNA-based and protein HIV vaccines in various combinations shows that antibody and cellular immune response occurs within 6 weeks from the date of vaccination, and the combination must be administered together for the most rapid protection. This will enable more large-scale testing of the vaccine for effectiveness. About 40 million people today have HIV infections, and 1.2 million deaths a year are related to this infection.

1 Oct 2019

Interprofessional collaboration may help improve patients' access to HIV testing and primary care

Getting better access to testing and proper primary care for individuals vulnerable to HIV could be as simple as a telephone call or email among health providers.

1 Oct 2019

Domestic violence may affect mothers' breastfeeding practices in developing countries

Mothers who have suffered from domestic violence are substantially less likely to follow recommended breastfeeding practices in low to middle-income countries, a new study shows.

1 Oct 2019

US Government to fund development of a 'universal flu vaccine'

The US government is to provide up to 400 million USD in funding to develop a “universal” flu vaccination at Duke University over the next seven years.

1 Oct 2019

Infectious disease experts explain how to stay healthy during the flu season

About 40 million people contracted the flu last year, with hundreds of thousands hospitalized and 35,400 to 61,000 deaths, including 134 children, according to the Centers for Disease Control and Prevention.

30 Sep 2019

Duke Human Vaccine Institute participates in a large national effort to improve flu shots

As part of a massive national effort to improve and modernize flu shots, the Duke Human Vaccine Institute has received three research contracts from the National Institute of Allergy and Infectious Diseases, with an initial award of approximately $29.6 million in first-year funding.

30 Sep 2019

Limited research on prevention of sexual violence against women in sub-Saharan Africa

Sexual violence is a human rights issue and a women's health issue. Without adequate research-based knowledge, neither health services nor the justice system can offer victims the help they need.

27 Sep 2019

NIH awards $30 million to accelerate progress in TB vaccine development

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded $30 million in first-year funding to establish new centers for immunology research to accelerate progress in tuberculosis vaccine development.

26 Sep 2019